Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,481.20
(
-1.01%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
2.39%
)
Bitcoin
70,558.01
(
0.94%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: rkrw post# 87668

Thursday, 12/17/2009 4:27:25 AM

Thursday, December 17, 2009 4:27:25 AM

Post# of 257264
Roche is certainly pursuing this strategy see this phase III trial of Tarceva vs.chemo, in 1st line NSCLC patients with EGFR mutation positive (completion expected end of 2010).

http://clinicaltrials.gov/ct2/show/NCT00446225
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today